Developing Growth Fund
Daily price w/o sales charge as of 04/07/2020
$15.37
$0.04
YTD Returns w/o sales charge as of 04/07/2020
-17.50%
Overall Morningstar RatingsSmall Growth
as of 03/31/2020
Morningstar rated the Lord Abbett Developing Growth Fund class R3 share 5, 3 and 4 stars among 577, 502 and 381 Small Growth Funds for the overall rating and the 3, 5 and 10 year periods ended 3/31/2020, respectively.
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.
Fund Basicsas of 02/28/2020
- Total Net Assets
- $1.75 B
- Inception Date
- 09/28/2007
- Dividend Frequency
- Annually
- Fund Expense Ratio
- 1.19%
- Number of Holdings
- 94
Fund Expense Ratio :
1.19%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | -17.02% | -13.93% | 11.08% | 4.10% | 11.19% | 7.60% |
| Lipper Category Avg. Small-Cap Growth Funds | -23.79% | -16.89% | 2.48% | 3.05% | 9.06% | - |
| Russell 2000® Growth Index | -25.76% | -18.58% | 0.10% | 1.70% | 8.89% | 5.87% |
Fund Expense Ratio :
1.19%
Fund Expense Ratio :
1.19%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | -17.02% | -13.93% | 11.08% | 4.10% | 11.19% | 7.60% |
| Lipper Category Avg. Small-Cap Growth Funds | -23.79% | -16.89% | 2.48% | 3.05% | 9.06% | - |
| Russell 2000® Growth Index | -25.76% | -18.58% | 0.10% | 1.70% | 8.89% | 5.87% |
Fund Expense Ratio :
1.19%
Returns with sales charges reflect a maximum sales charge of 5.75%.
TEN LARGEST HOLDINGS as of 02/28/2020View Portfolio
| Holding | Assets |
|---|---|
| Inspire Medical Systems Inc | 2.5% |
| Generac Holdings, Inc. | 2.2% |
| Inphi Corp. | 2.1% |
| YETI Holdings Inc | 1.9% |
| Five9, Inc. | 1.9% |
| Paylocity Holding Corp. | 1.8% |
| Teladoc Health | 1.7% |
| SolarEdge Technologies, Inc. | 1.7% |
| Nevro Corp. | 1.7% |
| Alteryx Inc | 1.7% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 02/28/2020View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
Investment Team
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
1.19%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | -17.02% | -13.93% | 11.08% | 4.10% | 11.19% | 7.60% |
| Lipper Category Avg. Small-Cap Growth Funds | -23.79% | -16.89% | 2.48% | 3.05% | 9.06% | - |
| Russell 2000® Growth Index | -25.76% | -18.58% | 0.10% | 1.70% | 8.89% | 5.87% |
Fund Expense Ratio :
1.19%
Fund Expense Ratio :
1.19%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 09/28/2007 |
|---|
| w/o sales charge | -17.02% | -13.93% | 11.08% | 4.10% | 11.19% | 7.60% |
| Lipper Category Avg. Small-Cap Growth Funds | -23.79% | -16.89% | 2.48% | 3.05% | 9.06% | - |
| Russell 2000® Growth Index | -25.76% | -18.58% | 0.10% | 1.70% | 8.89% | 5.87% |
Fund Expense Ratio :
1.19%
Returns with sales charges reflect a maximum sales charge of 5.75%.
| Year | Fund Returns | Russell 2000® Growth Index |
|---|
| 2019 | 31.63% | 28.48% |
| 2018 | 4.79% | -9.31% |
| 2017 | 29.64% | 22.17% |
| 2016 | -2.99% | 11.32% |
| 2015 | -9.10% | -1.38% |
| 2014 | 3.09% | 5.60% |
| 2013 | 56.97% | 43.30% |
| 2012 | 10.20% | 14.59% |
| 2011 | -1.81% | -2.91% |
| 2010 | 36.27% | 29.09% |
| 2009 | 46.84% | - |
| 2008 | -47.57% | - |
| 2007 | 35.63% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2020 | -17.02% | - | - | - | -17.50% |
| 2019 | 26.92% | 9.07% | -11.41% | 7.34% | 31.63% |
| 2018 | 7.05% | 14.94% | 12.10% | -24.03% | 4.79% |
| 2017 | 8.28% | 4.01% | 7.00% | 7.58% | 29.64% |
| 2016 | -10.36% | 2.16% | 10.77% | -4.37% | -2.99% |
| 2015 | 7.06% | 2.57% | -15.74% | -1.76% | -9.10% |
| 2014 | 1.65% | 0.12% | -5.80% | 7.53% | 3.09% |
| 2013 | 13.48% | 10.00% | 18.72% | 5.92% | 56.97% |
| 2012 | 12.15% | -2.74% | 5.55% | -4.27% | 10.20% |
| 2011 | 10.19% | 1.46% | -20.89% | 11.03% | -1.81% |
| 2010 | 8.10% | -7.97% | 16.48% | 17.59% | 36.27% |
| 2009 | -2.17% | 24.23% | 14.22% | 5.78% | 46.84% |
| 2008 | -21.83% | 6.59% | -11.82% | -28.64% | -47.57% |
| 2007 | 4.60% | 13.56% | 9.80% | 3.99% | 35.63% |
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Inspire Medical Systems Inc | Health Care | 2.5% |
| Generac Holdings, Inc. | Industrials | 2.2% |
| Inphi Corp. | Information Technology | 2.1% |
| YETI Holdings Inc | Consumer Discretionary | 1.9% |
| Five9, Inc. | Information Technology | 1.9% |
| Paylocity Holding Corp. | Information Technology | 1.8% |
| Teladoc Health | Health Care | 1.7% |
| SolarEdge Technologies, Inc. | Information Technology | 1.7% |
| Nevro Corp. | Health Care | 1.7% |
| Alteryx Inc | Information Technology | 1.7% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Inspire Medical Systems Inc | Health Care | 2.5% |
| Generac Holdings, Inc. | Industrials | 2.2% |
| Inphi Corp. | Information Technology | 2.1% |
| YETI Holdings Inc | Consumer Discretionary | 1.9% |
| Five9, Inc. | Information Technology | 1.9% |
| Paylocity Holding Corp. | Information Technology | 1.8% |
| Teladoc Health | Health Care | 1.7% |
| SolarEdge Technologies, Inc. | Information Technology | 1.7% |
| Nevro Corp. | Health Care | 1.7% |
| Alteryx Inc | Information Technology | 1.7% |
| Bright Horizons Family Solutions, Inc. | Consumer Discretionary | 1.6% |
| eHealth, Inc. | Financials | 1.6% |
| Chegg, Inc. | Consumer Discretionary | 1.6% |
| Redfin Corp | Real Estate | 1.6% |
| Planet Fitness, Inc. | Consumer Discretionary | 1.6% |
| SVMK Inc | Information Technology | 1.5% |
| Avalara Inc | Information Technology | 1.5% |
| LGI Homes, Inc. | Consumer Discretionary | 1.5% |
| Axon Enterprise, Inc. | Industrials | 1.5% |
| Monolithic Power Systems, Inc. | Information Technology | 1.4% |
| Coupa Software Inc | Information Technology | 1.3% |
| MKS Instruments, Inc. | Information Technology | 1.3% |
| Insulet Corp. | Health Care | 1.3% |
| Mirati Therapeutics, Inc. | Health Care | 1.3% |
| Verra Mobility Corp | Information Technology | 1.3% |
| Bridgebio Pharma Inc | Health Care | 1.2% |
| Western Alliance Bancorp | Financials | 1.2% |
| Freshpet, Inc. | Consumer Staples | 1.2% |
| Globant SA | Information Technology | 1.2% |
| Helen of Troy Ltd. | Consumer Discretionary | 1.2% |
| Argenx SE | Health Care | 1.2% |
| Masimo Corp. | Health Care | 1.2% |
| Federal Signal Corp. | Industrials | 1.2% |
| Repligen Corp. | Health Care | 1.1% |
| Penumbra, Inc. | Health Care | 1.1% |
| Tetra Tech, Inc. | Industrials | 1.1% |
| National Vision Holdings Inc | Consumer Discretionary | 1.1% |
| Assetmark Financial Holdings Inc | Financials | 1.0% |
| 10X Genomics Inc | Health Care | 1.0% |
| Malibu Boats, Inc. | Consumer Discretionary | 1.0% |
| Lithia Motors, Inc. | Consumer Discretionary | 1.0% |
| Forty Seven Inc | Health Care | 1.0% |
| Guardant Health Inc | Health Care | 1.0% |
| Everbridge, Inc. | Information Technology | 1.0% |
| Evoqua Water Technologies Corp | Industrials | 1.0% |
| Deckers Outdoor Corp. | Consumer Discretionary | 1.0% |
| Wingstop, Inc. | Consumer Discretionary | 1.0% |
| Cirrus Logic, Inc. | Information Technology | 1.0% |
| Iovance Biotherapeutics Inc | Health Care | 1.0% |
| Lumentum Holdings, Inc. | Information Technology | 1.0% |
| Axonics Modulation Technologies Inc | Health Care | 0.9% |
| Beyond Meat Inc | Consumer Staples | 0.9% |
| Sarepta Therapeutics, Inc. | Health Care | 0.9% |
| Acceleron Pharma, Inc. | Health Care | 0.9% |
| Boston Beer Co., Inc. | Consumer Staples | 0.9% |
| Trex Co., Inc. | Industrials | 0.9% |
| Eldorado Resorts, Inc. | Consumer Discretionary | 0.9% |
| Strategic Education, Inc. | Consumer Discretionary | 0.9% |
| ChemoCentryx Inc | Health Care | 0.8% |
| Goosehead Insurance Inc | Financials | 0.8% |
| iRhythm Technologies, Inc. | Health Care | 0.8% |
| Q2 Holdings, Inc. | Information Technology | 0.8% |
| Quanta Services, Inc. | Industrials | 0.8% |
| Silicon Laboratories, Inc. | Information Technology | 0.7% |
| Cardlytics Inc | Information Technology | 0.7% |
| Restoration Hardware Holdings, Inc. | Consumer Discretionary | 0.7% |
| Turning Point Therapeutics Inc | Health Care | 0.7% |
| MasTec, Inc. | Industrials | 0.7% |
| Karuna Therapeutics Inc | Health Care | 0.7% |
| Rocket Pharmaceuticals Inc | Health Care | 0.7% |
| Blueprint Medicines Corp. | Health Care | 0.6% |
| CRISPR Therapeutics AG | Health Care | 0.6% |
| HubSpot, Inc. | Information Technology | 0.6% |
| Novanta Inc | Information Technology | 0.6% |
| Medallia Inc | Information Technology | 0.6% |
| Natera, Inc. | Health Care | 0.5% |
| PTC Therapeutics, Inc. | Health Care | 0.5% |
| Coherus Biosciences, Inc. | Health Care | 0.5% |
| Blackline, Inc. | Information Technology | 0.5% |
| Comtech Telecommunications Corp. | Information Technology | 0.5% |
| Anaplan Inc | Information Technology | 0.5% |
| Grocery Outlet Holding Corp | Consumer Staples | 0.5% |
| Semtech Corp. | Information Technology | 0.5% |
| Appian Corp | Information Technology | 0.5% |
| GW Pharmaceuticals plc | Health Care | 0.5% |
| Arena Pharmaceuticals, Inc. | Health Care | 0.5% |
| Deciphera Pharmaceuticals Inc | Health Care | 0.5% |
| NextCure Inc | Health Care | 0.4% |
| uniQure NV | Health Care | 0.4% |
| Aerovironment, Inc. | Industrials | 0.4% |
| Myovant Sciences Ltd | Health Care | 0.3% |
| Glaukos Corp. | Health Care | 0.3% |
| Zymeworks Inc | Health Care | 0.2% |
| RealReal Inc/The | Consumer Discretionary | 0.1% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 02/28/2020
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
0.1%
|
|
| Real Estate |
 0.8%
|
|
| Utilities | 0.0% | |
| Consumer Discretionary |
0.3%
|
|
| Consumer Staples | 0.0% | |
| Energy | 0.0% | |
| Financials |
0.5%
|
|
| Health Care |
0.3%
|
|
| Industrials |
1.8%
|
|
| Information Technology |
0.9%
|
|
| Materials | 0.0% |
Portfolio Details as of 02/28/2020
- Total Net Assets
- $1.75 B
- Number of Holdings
- 94
- Weighted Average Market Cap.
- 4.4 B
- P/B Ratio
- 6.4x
- Portfolio Turnover Ratio as of 07/31/2019
- 88.2%
- P/E Ratio
- 29.4x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 12/31/2019
Contributors
| Holding | Contribution |
|---|---|
| Generac Holdings, Inc. | 0.7% |
| Mirati Therapeutics, Inc. | 0.7% |
| Nevro Corp. | 0.6% |
| Bridgebio Pharma Inc | 0.5% |
| Yeti Hldgs Inc | 0.4% |
Detractors
| Holding | Contribution |
|---|---|
| The Realreal Inc | -0.4% |
| Sage Therapeutics, Inc. | -0.3% |
| LGI Homes, Inc. | -0.2% |
| Appian Corp | -0.2% |
| Huya Inc | -0.2% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Developing Growth Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2020 | 11/24/2020 | 11/24/2020 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/20/2019 | 11/21/2019 | $4.4885 | - | $4.4885 | $17.81 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Upcoming Capital Gain Distribution
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date |
|---|---|
| 11/23/2020 | 11/24/2020 |
Fees & Expenses
Fees & Expenses
Expense Ratioas of 03/31/2020
| 1.19% |
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
| n/a |
Prospectus (XBRL)
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||